joint
-
Agilent Technologies and University of Technology, Sydney, open joint nuclear magnet resonance facility
NMR facility will be home to cutting-edge technology to support a range of UTS staff and student research projects.
joint | 20 October 2011
-
FUJIFILM, Dr Reddy's establish exclusive joint venture on generic drugs in Japan
FUJIFILM Corporation President and CEO, Shigetaka Komori and Dr Reddy's Laboratories Ltd Vice-Chairman and CEO, G V Prasad signed a memorandum of understanding to enter into an exclusive partnership in the generic drugs business for the Japanese mark…
joint | 29 July 2011
-
Merck and Simcere to establish China joint venture
Merck & Co Inc and China’s Simcere Pharmaceutical Group announced the signing of a framework agreement to establish a joint venture focused on serving China's rapidly expanding health care needs by providing significantly improved access to quality…
joint | 25 July 2011
-
MingSight and Relin form joint venture in China
Shenzhen Relin Medicine and MingSight Pharmaceuticals announced the formation of a joint venture, Jiangsu MingSight-Relin Pharmaceutical Co Ltd to develop and commercialize an innovative treatment for diabetic eye disease in China. MingSight-Relin…
joint | 07 July 2011
-
Merck and Simcere to establish China joint venture
Merck & Co Inc and China's Simcere Pharmaceutical Group announced the signing of a framework agreement to establish a joint venture focused on serving China's rapidly expanding health care needs by providing significantly improved access to quality m…
joint | 01 July 2011
-
Roche and Evotec to jointly develop biomarkers in oncology
An alliance for personalized healthcare in cancer research and development.
joint | 24 June 2011
-
Merck, Sun Pharma establish joint venture on generics
Joint venture to apply proprietary technologies to develop medicines designed to enhance convenience and improve compliance
joint | 12 April 2011
-
SAFC and Novozymes extend joint agreement
SAFC , a member of the Sigma-Aldrich Group and Novozymes Biopharma agreed on a 10-year extension of their joint agreement under which SAFC retains exclusive marketing and distribution rights for Novozymes Biopharma’s LONGR³IGF-I (LONGR3) growth f…
joint | 05 October 2010
-
Artes and Rhein Minapharm Continue Joint Product Development
Artes Biotechnology and Rhein Minapharm Biogenetics have jointly announced the production of a target of a therapeutic protein. The former applied its Hansenula technology platform and know-how to the generation of a therapeutic protein that was cho…
joint | 01 January 2010
-
Philips and Celsion Advance Development of Cancer Drug
Royal Philips Electronics and Celsion Corporation have announced the results of their joint research program to evaluate ThermoDox – the latter company’s heat-activated liposomal drug, in combination with magnetic resonance guided high intensity …
joint | 19 October 2009
